• Co-founded RevIVe Medtech GmbH, a Medtech company, focusing on innovative healthcare solutions.• Leading the creation of a state-of-the-art IV therapy solution designed for outpatient parenteral antibiotic therapy.• Secured public funding to support and accelerate product development and company growth.• Formulated a robust business case to showcase the financial viability and potential return on investment of the product.• Assembled a medical advisory board consisting of international experts to provide insights and consultation.• Building strategic alliances and partnerships, optimizing the company's competitive positioning.• Designing and implementing an effective patent strategy, which has successfully resulted in filing of two patent applications to date (inventor and applicant).• Collaborated with the University of Linz on prototype design and development.• Driving the development strategy and plan while ensuring the scientific positioning aligns with company's mission.• Supervising bachelor's and master's students, guiding their academic and professional growth.Further information: www.revivemedtech.com

Data & Digital Network Lead Drug Product Development, Member Biologics Environmental Sustainability Network- Driving the Data and Digital (D&D) transformation - Lead the Drug Product Development Network through objectives settings, strategy implementation aligned with global D&D strategy.- Identify D&D needs and priorities based on department strategy in alignment with company strategy.- Be the SPOC for D&D topics related to Drug Product Development, foster the information exchange and collaboration between department and the global D&D Stakeholders, identify opportunities for leveraging on existing projects.- Support the cultural change required for the digital transformation.- Champion and advocate the adoption of digital technologies and tools that facilitate data-driven decision-making and operational excellence.- Effectively communicate project progress, milestones, resources situation, risks, and issues to leadership team and stakeholders at various levels to facilitate informed decision-making.- Ensure transparent communication to associates.

• Successfully identified differentiation opportunities within the field of small-molecule compounds and facilitated their transition towards full-scale development.• Led cross-functional teams, including technical, medical, regulatory, portfolio, IP, and commercial units in a strategic, analytical evaluation of potential differentiation opportunities (oral, parenteral, digital and drug-device combination products).• Devised comprehensive development strategies for selected opportunities. This planning included market potential evaluations, timeline estimates, resource requirement projections, and the calculation of probabilities of success, empowering informed decision making regarding full-scale development investments.• Directed scientific proof-of-concept projects for effective risk mitigation. These projects focused on addressing potential technical, medical, regulatory, and commercial uncertainties before committing resources to full-scale development.• Fostered beneficial scientific collaborations and effectively secured funding for the Sandoz Development Center in Kundl.• Dynamic member of the disruptive innovation cluster within the digital transformation group, consistently driving technological progress and innovation initiatives.

• Conducted technical evaluations (including assessment of the technical probability of success and patent risks) for oral and parenteral generic small-molecule products to determine the full-development strategy (1:1 copy vs. design around) comprising API solid state and final dosage form production processes selection (e.g. spray drying, crystallisation, lyophilisation, fluidized-bed coating, powder filling, and tabletting)• Supported the formation of a robust generic molecule patent strategy through the filing of intellectual property rights, enhancing the company's competitive positioning.• Evaluated and implemented innovation concepts, such as SPRINT methodology and Design Thinking approach.• Served as the local point of contact for the digital transformation initiative at the Sandoz Development Center in Kundl.• As a member of the Accelerate Gx team, contributed to a global OPEX initiative aimed at shortening generic development timelines.• Coordinated the JET (Joined Expert and Technician) training program, supporting skill development and knowledge transfer within the organization.

• Responsible for building the company's respiratory portfolio by managing the selection and process development of standard and tailor-made inhalative excipients.• Actively contributed to scientific discourse in the industry through authoring, publishing and peer-reviewing research papers.• Presented research findings at various scientific conferences, increasing brand visibility and presence in the scientific community.• Fostered scientific collaborations to fuel innovation and knowledge exchange.• Provided comprehensive global application support. Feedback received from our customers was instrumental in guiding our development of new products, ensuring we constantly improve and adapt to market needs.

Development of alternative carrier particles with optimized surface roughness for dry powder inhalation* Spray Drying incl. scale-up* Powder Characterization (Size, Shape, Surface roughness, BET, MIP, He-Pycnometry,...)* DPI Formulation Development* DPI Analytics

* GMP inspections